Skip to main content
Premium Trial:

Request an Annual Quote

Institut Curie to Use GE Healthcare s IN Cell Analyzer for Cancer Research

NEW YORK, June 21 (GenomeWeb News) - GE Healthcare said today that the Paris-based Institut Curie will use its IN Cell Analyzer 1000 sub-cellular imaging system for a new research project.

 

The study, called the 'BioPhenics' project, plans to use cell biology and microscopic imaging to advance cancer drug discovery. The project will initially focus on breast and lung cancer, GE Healthcare said.

 

Institut Curie will use the IN Cell Analyzer to observe cells in culture in order to study cellular behavior and responses. GE Healthcare said that the institute will use the system for a range of biological applications, including screening, lead profiling, target validation, and assay development. 

 

Financial terms of the agreement were not provided.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.